Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 168Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Sodium glucose co-transporter 2 inhibitors for glycemic control in type 2 diabetes mellitus: Quality of reporting of randomized controlled trials

Mittal Niti, Mittal Rakesh, Kumar Harish, Medhi Bikash

Year : 2016| Volume: 7| Issue : 1 | Page no: 21-27

   This article has been cited by
 
1 A Review of Adherence and Predictors of Adherence to the CONSORT Statement in the Reporting of Tuberculosis Vaccine Trials
Veranyuy D. Ngah,Akhona V. Mazingisa,Moleen Zunza,Charles S. Wiysonge
Vaccines. 2020; 8(4): 770
[Pubmed]  [Google Scholar] [DOI]
2 Clinical intervention studies of orofacial motricity: an analysis of the methodological quality of brazilian studies
James Tomaz-Morais,Jully Anne Soares de Lima,Brunna Thaís Luckwu-Lucena,Rebecca Rhuanny Tolentino Limeira,Sâmara Munique Silva,Giorvan Ânderson dos Santos Alves,André Ulisses Dantas Batista,Ricardo Dias de Castro
Revista CEFAC. 2018; 20(3): 388
[Pubmed]  [Google Scholar] [DOI]
3 Curcumin improves diabetes mellitus-associated cerebral infarction by increasing the expression of GLUT1 and GLUT3
Mingyu Xia,Zankai Ye,Yanfeng Shi,Libo Zhou,Yang Hua
Molecular Medicine Reports. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article